Skip to main content
OpenTrials
Completed

NCT Number: NCT03164421

N-Acetylcysteine and L-carnitine in Pcos

N-Acetylcysteine and L-carnitine were used in pcos patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

PCOS

Age range

18 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Zagazig University

Zagazig, Egypt

About this study

N-Acetylcysteine was compared to L-carnitine in clomiphene citrate in Pcos women to detect the hormonal and metabolic effect

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • pco
  • infertile

Exclusion criteria

  • no medical disorders
  • no hormonal treatment in the previous 3 months

Treatment and study plan

N-acetylcysteine

Drug

N-Acetylcysteine in clomiphene resistant pcos women

L-carnitine

Drug

L-carnitine in clomiphene resistant pcos women

Other names: motova plus

Primary outcomes

  1. pregnancy rate

    Time frame: 3 momths

    number of women with clinical pregnancy

Secondary outcomes

  1. ovulation rate

    Time frame: 3 momths

    number of women with follicle >18mm.

  2. abortion rate

    Time frame: 3 momths

    number of women with abortions

Sponsors and collaborators

Lead sponsor

Zagazig University

Other Gov

Registry information

Official study title

N-Acetylcysteine Versus L-carnitine in Clomiphene Citrate Resistant Pcos Women. a Randomized Controlled Trial

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
May 23, 2017
Registry last updated
Sep 18, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.